Completed
Endocrine active chemicals (EACs) have raised concerns that traditional toxicity-testing protocols might be inadequate to identify all potential hazards to human health because they have the ability to modulate normal hormone function, and small alterations in hormone concentrations, particularly during sensitive life stages, can have lasting and significant effects. To address concerns about potential human health effects from EACs at low doses, this report develops a strategy to evaluate the evidence for such low-dose effects.
Low Dose Committee Mtg.9
- March 2 - 3, 2017
- Closed
- Past
Low Dose Committee Mtg.8
- January 12 - 13, 2017
- Closed
- Past
Low Dose Committee - Meeting 7
- November 10 - 11, 2016
- Closed
- Past
Low Dose Committee - Meeting 6
- September 14 - 15, 2016
- Closed
- Past
Low Dose Committee - Meeting 5
- July 27, 2016
- 12:00 AM - 12:00 AM (EDT)
- Closed
- Past
Low Dose Committee - Meeting 4
- April 26 - 27, 2016
- Closed
- Past
Low Dose Committee - Meeting 3
- February 3 - 5, 2016
- Closed
- Past
Low Dose Committee - Meeting 2
- November 17 - 18, 2015
- Closed
- Past
Low Dose Committee - Meeting 1
- October 13 - 14, 2015
- Closed
- Past
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.
About
Get in touch
Our People